Ozempic reduces severity of liver disease in people with HIV, study shows, ET HealthWorld
Bengaluru: A weekly injection of semaglutide was safe and reduced the amount of fat in the liver by 31 per cent in people with HIV and a type of liver disease, data from a mid-stage study funded by the National Institutes of Health showed. Data from the study was first released on Monday at the …